Bright-Eyed And Bushy Tailed: Purdue Launches Intermezzo
This article was originally published in The Pink Sheet Daily
Executive Summary
Purdue Pharma launched Transcept Pharmaceutical’s Intermezzo, a low-dose sublingual tablet version of the generic sleep aid zolpidem, for middle-of-the-night awakenings April 5. Priced at a wholesale acquisition cost of $6.45 per tablet, the drug could face an uphill commercial road competing against generics.